Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Published on: November 21, 2023

ESR/ERS statement paper on lung cancer screening.

Hans-Ulrich Kauczor¹, Anne-Marie Baird², Torsten Gerriet Blum³

¹Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, Heidelberg, Germany hans-ulrich.kauczor@med.uni-heidelberg.de.

The European Respiratory Journal

|February 14, 2020

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lung Transplantation for Pulmonary Alveolar Proteinosis - a Retrospective International Multi-Center Analysis.

The European respiratory journal·2026

Same author

Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILD.

Chest·2026

Same author

Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe.

European radiology·2026

Same author

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026

Same author

Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease.

Journal of clinical medicine·2026

Same author

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026

Summary

Lung cancer screening (LCS) in Europe requires updated guidelines for early diagnosis and reduced mortality. Key elements include participant outreach, shared decision-making, and robust quality standards for organized screening pathways.

Area of Science:

Oncology
Radiology
Public Health

Background:

Lung cancer is a leading cause of cancer death in Europe.
Significant advancements and discussions in lung cancer screening (LCS) have occurred since 2015.
An updated expert opinion is needed to review current LCS evidence and practices.

Purpose of the Study:

To provide an updated expert opinion on lung cancer screening in Europe.
To review evidence from LCS trials and describe current practices.
To highlight areas needing further attention in LCS implementation.

Main Methods:

A narrative, non-systematic review of evidence from LCS trials.
Description of the current practice of lung cancer screening.
Identification of key aspects for effective LCS implementation.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Published on: November 21, 2023

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

Main Results:

Effective LCS requires reaching high-risk individuals, optimal communication, and shared decision-making.
Standardized infrastructure, pathways, and quality assurance are crucial.
Addressing tobacco cessation, benefits/harms, overdiagnosis, radiation exposure, and cost-effectiveness is essential.

Conclusions:

European health systems must adapt to facilitate organized LCS pathways for early diagnosis and mortality reduction.
Demonstration programs are needed to focus on methodology, standardization, tobacco cessation, and cost-effectiveness.
A multidisciplinary approach involving various medical experts and patient representatives is vital for successful LCS.